Literature DB >> 27151395

Glucagon-like peptide-1 (GLP-1) analogues: A potential new treatment for alcohol use disorder?

Anders Fink-Jensen1, Tina Vilsbøll2.   

Abstract

Entities:  

Year:  2016        PMID： 27151395     DOI： 10.1080/08039488.2016.1176252

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN： 0803-9488            Impact factor:   2.202


× No keyword cloud information.
  4 in total

Review 1.  The dopamine motive system: implications for drug and food addiction.

Authors:  Nora D Volkow; Roy A Wise; Ruben Baler
Journal:  Nat Rev Neurosci       Date:  2017-11-16       Impact factor: 34.870

Review 2.  The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.

Authors:  Mette Kruse Klausen; Morgane Thomsen; Gitta Wortwein; Anders Fink-Jensen
Journal:  Br J Pharmacol       Date:  2022-02       Impact factor: 9.473

3.  Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial.

Authors:  Kerstin K Antonsen; Mette K Klausen; Amanda S Brunchmann; Nina le Dous; Mathias E Jensen; Kamilla Woznica Miskowiak; Patrick M Fisher; Gerda K Thomsen; Henrik Rindom; Thomas P Fahmy; Sabine Vollstaedt-Klein; Helene Benveniste; Nora D Volkow; Ulrik Becker; Claus Ekstrøm; Gitte Moos Knudsen; Tina Vilsbøll; Anders Fink-Jensen
Journal:  BMJ Open       Date:  2018-07-16       Impact factor: 2.692

4.  Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.

Authors:  Annika Billefeld Bornebusch; Anders Fink-Jensen; Gitta Wörtwein; Randy J Seeley; Morgane Thomsen
Journal:  eNeuro       Date:  2019-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.